Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122241
Filing Date
2024-11-06
Accepted
2024-11-06 16:01:32
Documents
69
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q scyx-20240930.htm   iXBRL 10-Q 1930458
2 EX-31.1 scyx-ex31_1.htm EX-31.1 17212
3 EX-31.2 scyx-ex31_2.htm EX-31.2 17720
4 EX-32.1 scyx-ex32_1.htm EX-32.1 10977
  Complete submission text file 0000950170-24-122241.txt   9731377

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT scyx-20240930.xsd EX-101.SCH 1199470
72 EXTRACTED XBRL INSTANCE DOCUMENT scyx-20240930_htm.xml XML 2240766
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36365 | Film No.: 241430781
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)